Secondary prevention in coronary heart disease

Journal of Human Nutrition and Dietetics

Volumn 9, Issue 5, 1996, Pages 363-371

  Haq, I U ^a   Minnis, R C ^a   Jackson, P R ^a   Yeo, W W ^a   Ramsay, L E ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Cholesterol; Coronary heart disease; Diet; HMG CoA reductase inhibitors; Secondary prevention

Indexed keywords

CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONFERENCE PAPER; CORONARY RISK; DIET RESTRICTION; EXERCISE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL PRACTICE; PROGNOSIS; SECONDARY PREVENTION; WEIGHT REDUCTION;

EID: 0029909543     PISSN: 09523871     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-277X.1996.00470.x     Document Type: Conference Paper

References (57)

1. Åberg, A., Bergstrand, R., Johansson, S., et al. (1983) Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br. Heart J. 49, 416-422.
2. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342, 821-828.
3. Antiplatelet Trialists' Collaboration (1994) Collaborative overview of randomised trial of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. 308, 81-106.
4. Ascherio, A., Rimm, E.B., Stampfer, M.J., Giovannucci, E.L. & Willett, W.C. (1995) Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N. Engl. J. Med. 332, 977-982.
5. ASPIRE Steering Group (1996) A British Cardiac Society survey of the potential for the secondary prevention of coronary heart disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart 75, 334-342.
6. Bennett, N., Dodd, T., Flatley, J., Freeth, S., Boiling, K., for the Office of Population and Censuses Surveys (1995) Health Survey for England 1993. London: HMSO.
7. Betteridge, D.J., Dodson, P.M., Durrington, P.N., et al. (1993) Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad. Med. J. 69, 359-369.
8. Burr, M.L., Fehily, A.M., Gilbert, J.F., et al. (1989) Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2, 757-761.
9. Burt, A., Thornley, P., Illingworth, D., White, P., Shaw, T.R.D. & Tuner, R. (1974) Stopping smoking after myocardial infarction. Lancet 1, 304-306.
10. Coronary Drug Project Research Group (1982) The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men: the 5-year findings of the Coronary Drug Project. Circulation 39, 197-209.
11. Cupples, M.E. & McKnight, A. (1994) Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. Br. Med. J. 309, 993-996.
12. Davey Smith, G., Song, F. & Sheldon, T.A. (1993) Cholesterol lowering and mortality: the importance of considering initial level of risk. Br. Med. J. 306, 1367-1373.
13. Dyerberg, J., Bang, H.O., Stofferson, E., Moncada, S. & Vane, J.R. (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2, 117-119.
14. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (1993) Summary of the second report of the national cholesterol education program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel II). JAMA 269, 3015-3023.
15. Gould, A.L., Rossouw, J.E., Santanello, N.C., et al. (1995) Cholesterol reduction yields clinical benefit. A new look at old data. Circulation 91, 2274-2282.
16. Haq, I.U., Jackson, P.R., Yeo, W.W. & Ramsay, L.E. (1995) Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 346, 1467-1471.
17. Hulley, S.B., Walsh, J.M.B. & Newman, T.B. (1992) Health policy in blood cholesterol: time to change directions. Circulation 86, 1026-1029.
18. Hunninghake, D.B., Stein, E.A., Dujovne, C.A., et al. (1993) The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N. Engl. J. Med. 328, 1213-1219.
19. Howard, W.J. & Brown, W. V. (1988) Pharmacologic therapy of hypercholesterolaemia. Cure. Opin. Cardiol 3, 525-541.
20. International Task Force for prevention of coronary heart disease (1992) Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society. Nutr. Metab. Cardiovasc. Dis. 2, 113-156.
21. ISIS-I (First International Study of Infarct Survival) Collaborative Group (1986) Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-I. Lancet 2, 57-66.
22. Kromhout, D., Bosscbieter, E.B. & Coulander, C. de L. (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med. 312, 1205-1209.
23. Law, M.R., Wald, N.J. & Thompson, S.G. (1994) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br. Med. J. 308, 367-372.
24. Lipid Research Clinics Programme (1984) The lipid research clinics coronary primary prevention trial results 1: reduction in incidence of coronary heart disease. JAMA 251, 351-364.
25. de Lorgeril, M., Renaud, S., Mamelle, N., et al. (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343, 1454-1459.
26. Manninen, V., Elo, M.O., Frick, M.H., et al. (1988) Lipid alterations and decline in the incidence of coronary heart disease Helsinki Heart Study. JAMA 260, 641-651.
27. Martin, M.J., Hulley, S.B., Browner, W.S., et al. (1986) Serum cholesterol, blood pressure and mortality: implications from a cohort of 361, 662 men. Lancet 2, 933-936.
28. McKeigue, P. (1994) Diets for secondary prevention of coronary heart disease: can linolenic acid substitute for oily fish? Lancet 343, 1445.
29. Morrison, C., McCluskey, M.K. & Tunstall-Pedoe, H. (1996) Cholesterol - Whom do we test and whom should we test. Br. Heart J. (Suppl. 1) 75, 114.
30. Neaton, J.D. & Wentworth, D. (1992) Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Arch. Intern. Med. 152, 56-64.
31. O'Connor, G.T., Burling, J.E., Yusuf, S., et al. (1989) An overview of randomised trials of rehabilitation with exercise after myocardial infarction. Circulation 80, 234-244.
32. Oliver, M., Poole-Wilson, P., Shepherd, J. & Tikkanen, M.J. (1995) Lower patient's cholesterol now. Br Med. J. 310, 1280-1281.
33. Pfeffer, M.A., Braunwald, E., Moyé, L.A. et al. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327, 669-677.
34. Pyöralä, K., De Backer, G., Graham, I., Poole-Wilson, P., Wood, D., on behalf of the Task Force. Prevention of coronary heart disease in clinical practice (1994) Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur. Heart. J. 15, 1300-1331.
35. Ramsay, L.E., Yeo, W.W. & Jackson, PR. (1991) Dietary reduction of serum cholesterol concentration: time to think again. Br. Med. J. 303, 953-957.
36. Ramsay, L.E., Yeo, W.W. & Jackson, P.R. (1994) Ischaemic heart disease and cholesterol. Effective diets are unpalatable. Br. Med. J. 308, 1038-1039.
37. Rimm, E.B., Stampfer, M.J., Ascherio, A., Giovannucci, E., Colditz, G.A, & Willett, W.C. (1993) Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328, 1450-1456.
38. Roberts, W.C. (1994) The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels. Am. J. Cardiol. 73, 623-624.
39. Rogers, S., James, K.S., Burtland, B.K., Etherington, M.D., O'Brien, J.R. & Jones, J.G. (1987) Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables: a double-blind randomised controlled trial in healthy volunteers. Atherosclerosis 63, 137-143.
40. Royal College of General Practitioners (1992) Guidelines for the Management of Hyperlipidaemia in General Practice. Towards the Primary Prevention of Coronary Heart Disease. Occasional Paper 55. London: The Royal College of General Practitioners, pp. 1-15.
41. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of choleserol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389.
42. Shaper, A.G., Cook, D.G., Walker, M. & MacFarlane, P.W. (1984) Prevalence of ischaemic heart disease in middle aged British men. Br. Heart J. 51, 595-605.
43. Shaper, A.G., Pocock, S.J., Walker, M., Phillips, A.N., Whitehead, T.P. & MacFarlane, P.W. (1985) Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J. Epidemiol. Community Health 39, 197-209.
44. Shaper, A.G. & Wannamethee G. (1991) Physical activity and ischaemic heart disease in middle-aged British men. Br. Heart J. 66, 384-394.
45. Shepherd, J., Betteridge, D.J. & Durrington, P. (1987) Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br. Med. J. 295, 1245-1246.
46. Shepherd, J., Cobbe, S.M., Ford, I., et al., for the West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N. Engl. J. Med. 333, 1301-1307.
47. Stampfer, M.J., Hennekens, C.H., Manson, J.E., Colditz, G.A., Rosner, B. & Willett, W.C. (1993) Vitamin E consumption and the risk of coronary heart disease in women. M Engl. J. Med. 328, 1444-1449.
48. Steinberg, D. (1993) Antioxidant vitamins and coronary heart disease. N. Engl. J. Med. 328, 1487-1489.
49. Stephens, N.G., Parsons, A., Schofield, P.M., et al. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786.
50. Thompson, G.R. (1989a) Current management of hyperlipidaemia. Br. J. Hosp. Med. 42, 268-274.
51. Thompson, G.R. (1989b) Management of hyperlipidaemia. Prescribers Journal 29, 221-233.
52. Tunstall-Pedoe, H., Smith, W.C.S. & Tavendale, R. (1989) How-often-that-high graphs of serum cholesterol. Findings from the Scottish Heart Health and Scottish MONICA Studies. Lancet 1, 540-542.
53. Tyroler, H.A. (1989) Overview of clinical trials of cholesterol lowering in relationship to epidemiologic studies. Am. J. Med. 87 (Suppl. 4A), 14-19.
54. Watts, G.F., Lewis, B., Brunt, J.N.H., et al. (1992) Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339, 563-569.
55. Wilhelmsson, C., Vedin, J.A., Elmfeldt, D., Tibblin, G. & Wilhelmsen L. (1975) Smoking and myocardial infarction. Lancet 1, 415-420.
56. World Health Organisation (1989) World Health Statistics Annual. Geneva: World Health Organisation.
57. Yusuf, S., Peto, R., Lewis, J., Collins, R. & Sleight, P. (1985) Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog. Cardiovasc. Dis. 27, 335-371.